
Sign up to save your podcasts
Or


The largest-ever clinical trial of a psychedelic drug will soon begin in Europe and North America. The drug is psilocybin - the active ingredient in magic mushrooms. The target is treatment-resistant depression.
By Rob Reid4.9
18391,839 ratings
The largest-ever clinical trial of a psychedelic drug will soon begin in Europe and North America. The drug is psilocybin - the active ingredient in magic mushrooms. The target is treatment-resistant depression.

43,854 Listeners

26,399 Listeners

4,280 Listeners

2,460 Listeners

943 Listeners

551 Listeners

598 Listeners

128 Listeners

939 Listeners

4,166 Listeners

6,461 Listeners

504 Listeners

566 Listeners

16,490 Listeners

501 Listeners